---
title: "Yunnan Botanee Bio-Technology Group Co. Ltd (300957.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300957.SZ.md"
symbol: "300957.SZ"
name: "Yunnan Botanee Bio-Technology Group Co. Ltd"
industry: "Personal Care Products"
datetime: "2026-05-21T16:08:42.988Z"
locales:
  - [en](https://longbridge.com/en/quote/300957.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300957.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300957.SZ.md)
---

# Yunnan Botanee Bio-Technology Group Co. Ltd (300957.SZ)

## Company Overview

Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup removers. It is also involved in the research, development, production, and sale of skincare related medical devices and electronic beauty instruments comprising hyaluronic acid repair bio membranes and hyaluronic acid repair dressings used for the protection and care of skin barrier damage after minimally invasive surgery; provision of provision of supply chain management, warehouse services, capital market, and consulting services.

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |
| Exchange | CN Market |
| Website | [www.botanee.com.cn](https://www.botanee.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: B (0.36)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 28 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -1.07% |  |
| Net Profit YoY | 53.25% |  |
| P/B Ratio | 2.64 |  |
| Dividend Ratio | 2.30% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 16488641189.25 |  |
| Revenue | 5517273304.85 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 8.93% | B |
| Profit Margin | 9.83% | B |
| Gross Margin | 73.35% | A |
| Revenue YoY | -1.07% | D |
| Net Profit YoY | 53.25% | B |
| Total Assets YoY | 8.77% | B |
| Net Assets YoY | 0.35% | C |
| Cash Flow Margin | 200.21% | B |
| OCF YoY | -1.07% | D |
| Turnover | 0.69 | B |
| Gearing Ratio | 24.71% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Yunnan Botanee Bio-Technology Group Co. Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-1.07%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "53.25%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.64",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.30%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "16488641189.25",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "5517273304.85",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "8.93%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "9.83%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "73.35%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-1.07%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "53.25%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "8.77%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.35%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "200.21%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-1.07%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.69",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "24.71%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 29.62 | 9/28 | 57.37 | 52.38 | 47.33 |
| PB | 2.57 | 13/28 | 3.22 | 3.07 | 2.82 |
| PS (TTM) | 2.91 | 18/28 | 3.66 | 3.44 | 3.28 |
| Dividend Yield | 2.36% | 8/28 | 2.14% | 1.37% | 1.30% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Proya (603605.SH) | A | D | A | B | C | B |
| 02 | BYHEALTH (300146.SZ) | B | C | C | A | C | B |
| 03 | BTN (300957.SZ) | B | C | B | B | C | B |
| 04 | FLYCO (603868.SH) | A | D | A | A | C | B |
| 05 | Shanghai Jahwa (600315.SH) | C | B | B | B | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T16:00:00.000Z

Total Analysts: **13**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 31% |
| Overweight | 1 | 8% |
| Hold | 7 | 54% |
| Sell | 1 | 8% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 37.99 |
| Highest Target | 61.00 |
| Lowest Target | 34.50 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300957.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300957.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300957.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300957.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**